A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Fibrogen Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 166,500 shares of FGEN stock, worth $148,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
166,500
Previous 683,412 75.64%
Holding current value
$148,185
Previous $606,000 35.48%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.73 - $2.73 $377,345 - $1.41 Million
-516,912 Reduced 75.64%
166,500 $391,000
Q4 2023

Feb 13, 2024

BUY
$0.38 - $0.91 $238,416 - $570,944
627,412 Added 1120.38%
683,412 $606,000
Q3 2023

Nov 14, 2023

BUY
$0.79 - $2.83 $44,240 - $158,480
56,000 New
56,000 $48,000
Q1 2023

May 12, 2023

SELL
$15.95 - $25.18 $3.54 Million - $5.59 Million
-222,200 Reduced 72.71%
83,400 $1.56 Million
Q4 2022

Feb 13, 2023

SELL
$13.27 - $17.73 $6.49 Million - $8.68 Million
-489,400 Reduced 61.56%
305,600 $4.9 Million
Q3 2022

Nov 14, 2022

BUY
$11.4 - $14.6 $448,020 - $573,780
39,300 Added 5.2%
795,000 $10.3 Million
Q2 2022

Aug 12, 2022

BUY
$7.94 - $12.96 $538,332 - $878,688
67,800 Added 9.86%
755,700 $7.98 Million
Q1 2022

May 13, 2022

BUY
$12.02 - $16.79 $7.08 Million - $9.89 Million
588,800 Added 594.15%
687,900 $8.27 Million
Q4 2021

Feb 11, 2022

SELL
$9.93 - $15.39 $1.09 Million - $1.69 Million
-109,539 Reduced 52.5%
99,100 $1.4 Million
Q3 2021

Nov 12, 2021

BUY
$10.18 - $26.64 $2.12 Million - $5.56 Million
208,639 New
208,639 $2.13 Million
Q2 2021

Aug 13, 2021

SELL
$18.57 - $35.68 $584,955 - $1.12 Million
-31,500 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$31.0 - $55.72 $471,200 - $846,944
15,200 Added 93.25%
31,500 $1.09 Million
Q4 2020

Feb 10, 2021

BUY
$37.09 - $48.97 $604,567 - $798,211
16,300 New
16,300 $605,000
Q3 2020

Nov 13, 2020

SELL
$40.47 - $45.5 $14.1 Million - $15.8 Million
-347,200 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$32.57 - $42.83 $11.3 Million - $14.9 Million
347,200 New
347,200 $14.1 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $83.4M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.